Peter Hersey

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Basal Cell Carcinoma

Top Venues

Pigment cell & melanoma research

British journal of cancer

Journal for immunotherapy of cancer

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Hersey, Hsin-Yi Tseng, Sara Alavi, Jessamy Tiffen
X and Y Differences in Melanoma Survival Between the Sexes. Pigment cell & melanoma research (2024)
Hsin-Yi Tseng, Sara Alavi, Stuart J Gallagher, Helen Marie McGuire, Peter Hersey, Abdullah Al Emran, Jessamy Tiffen
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment. Pigment cell & melanoma research (2024)
Jonathan S Cebon, Martin Gore, John F Thompson, Ian D Davis, Grant A McArthur, Euan T Walpole, Bernard Mark Smithers, Vincenzo Cerundolo, P Rod Dunbar, Duncan MacGregor, Cyril Fisher, Michael Millward, Paul Nathan, Michael P N Findlay, Peter Hersey, Thomas R Jeffry Evans, Christian Hermann Ottensmeier, Jeremy Marsden, Angus G Dalgleish, Philippa Corrie, Marples Maria, Margaret A Brimble, Geoff Williams, Sintia Winkler, Heather M Jackson, Liliana Endo-Munoz, Candani S A Tutuka, Ralph Venhaus, Lloyd J Old, Dennis Haack, Eugene Maraskovsky, Andreas Behren, Weisan Chen
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Journal for immunotherapy of cancer 8 (1) (2021)
Abdullah Al Emran, Stuart J Gallagher, Jessamy C Tiffen, Peter Hersey
Sex bias of females in survival from cancer and infections. Is X the answer? British journal of cancer 124 (7) (2021)
Hsin-Yi Tseng, Jan Dreyer, Abdullah Al Emran, Dilini Gunatilake, Mehdi Pirozyan, Carleen Cullinane, Ken Dutton-Regester, Helen Rizos, Nicholas K Hayward, Grant McArthur, Peter Hersey, Jessamy Tiffen, Stuart J Gallagher
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma. International journal of cancer 147 (8) (2020)